A5294112
Lonidamine , ≥99% , 50264-69-2
Synonym(s):
1-(2,4-Dichlorobenzyl)-1H-indazole-3-carboxylic acid;Diclondazolic acid
CAS NO.：50264-69-2
Empirical Formula: C15H10Cl2N2O2
Molecular Weight: 321.16
MDL number: MFCD00866285
EINECS: 256-510-0
| Pack Size | Price | Stock | Quantity |
| 5MG | RMB47.20 | In Stock |
|
| 25MG | RMB79.20 | In Stock |
|
| 100MG | RMB231.20 | In Stock |
|
| 250mg | RMB391.20 | In Stock |
|
| 1g | RMB1047.20 | In Stock |
|
| 5g | RMB3143.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 207-209°C |
| Boiling point: | 537.9±45.0 °C(Predicted) |
| Density | 1.4835 (rough estimate) |
| refractive index | 1.6070 (estimate) |
| storage temp. | Sealed in dry,2-8°C |
| solubility | Soluble in DMSO (up to 25 mg/ml). |
| form | solid |
| pka | 3.00±0.10(Predicted) |
| color | White |
| Stability: | Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 1 month. |
| InChIKey | WDRYRZXSPDWGEB-UHFFFAOYSA-N |
| CAS DataBase Reference | 50264-69-2(CAS DataBase Reference) |
Description and Uses
Lonidamine is an antineoplastic agent reportedly effective for the treatment of various cancers, including lung, breast, prostate and brain tumors. Its clinical effect appears to be associated with changes in cellular energy metabolism.
contraceptive, spermicidal
Safety
| Symbol(GHS) |   GHS07,GHS08 |
| Signal word | Danger |
| Hazard statements | H302-H351-H360 |
| Precautionary statements | P201-P301+P312+P330-P308+P313 |
| Hazard Codes | T |
| Risk Statements | 60-22-40 |
| Safety Statements | 53-22-36/37/39-45 |
| WGK Germany | 3 |
| RTECS | NK7886000 |
| HS Code | 29339900 |
| Toxicity | LD50 in mice, rats (mg/kg): 900, 1700 orally; 435, 525 i.p. (Heywood) |
